The Dalkon Shield lawsuit was not a single case but a wave of nearly 400,000 product liability claims filed against the A.H. Robins Company over injuries caused by its intrauterine contraceptive device, which was sold from the early 1970s until 1974. The litigation drove Robins into Chapter 11 bankruptcy in 1985, produced a court-ordered claimants trust that ultimately distributed close to $3 billion, and stands as one of the largest mass tort proceedings in American history.1Harvard Law School. Dalkon Shield Litigation Papers Donated to HLS
The Injuries Behind the Claims
Roughly two million American women were fitted with the Dalkon Shield. At least 18 died. At least 13,000 were left infertile. About 90,000 suffered major complications, including pelvic inflammatory disease, blood poisoning, spontaneous septic abortions, and ectopic pregnancies.2Washington Post. The Dalkon Shield Disaster
The mechanism of harm centered on the device’s tail string. Unlike single-filament threads used in competing IUDs, the Dalkon Shield’s string was a braided suture material made of roughly 400 tiny fibers wound together inside a nylon sheath. It behaved like a wick. Bacteria from the vagina collected in the microscopic spaces between fibers and traveled upward into the uterus, seeding infections. When a woman became pregnant with the device in place, those bacteria could infect the placenta and fetus.3Arizona State University Embryo Project Encyclopedia. The Dalkon Shield2Washington Post. The Dalkon Shield Disaster
Epidemiology backed up the individual injury stories. A 1975 CDC study concluded the Dalkon Shield carried a higher risk of abortion-related deaths than competing devices. A 1983 CDC report found elevated rates of pelvic inflammatory disease in users compared to both non-IUD users and users of other IUDs.4CDC MMWR. IUDs: Dalkon Shield A 1993 meta-analysis found the device produced roughly double the pregnancy rates of other IUDs and a five-fold increased risk of hospitalized pelvic infection.5Contraception Journal. IUDs and Upper-Genital-Tract Infections
What A.H. Robins Knew and Concealed
The company knew about the wicking problem as early as June 1970. Internal recommendations to heat-seal the nylon ends of the tail string, which might have blocked bacterial migration, were ignored. A quality control supervisor who repeatedly pushed for design changes was fired. In 1972, company consultant Dr. Thad Earl warned in writing that leaving the device in place during pregnancy could cause septic abortion. Robins continued selling the device and labeled it for use lasting “5 years or longer” to remain competitive.6SCIRP. The Dalkon Shield
The marketing rested on flawed science. The foundational 1970 study by co-inventor Hugh Davis used a small sample and short follow-up, excluded dropouts, and failed to disclose that Davis had recommended a backup contraceptive during the first three months after insertion. An internal document put the real pregnancy rate at 2.3%, not the 1.1% advertised. Davis also concealed his financial stake in the device when he testified before a U.S. Senate subcommittee in January 1970 and again under oath in 1974.6SCIRP. The Dalkon Shield7Washington Post. Researchers’ Ties Not Always Noted
In February 1975, after Robins had suspended U.S. sales, the company’s vice president and general counsel, William A. Forrest Jr., ordered internal documents destroyed. Former in-house attorney Roger L. Tuttle later testified that a project manager and a paralegal burned the papers in a forced-draft furnace normally used for contaminated products. Tuttle said the destroyed files contained evidence of what executives knew about the device’s dangers, its lack of premarket testing, and its flawed labeling. Before the burn, he secretly saved roughly 40 of the most sensitive documents.8Washington Post. Dalkon Shield Papers Were Burned, Says Ex-Robins Attorney
The Verdicts That Broke the Case Open
Lawsuits mounted through the mid-1970s and accelerated as the medical evidence hardened. By the end of 1984, more than 11,000 had been filed. A Colorado jury in May 1979 awarded Carie M. Palmer $600,000 in compensatory damages and $6.2 million in punitive damages after she suffered a septic abortion, septic shock, and a total hysterectomy following insertion of the device in 1973. The Colorado Supreme Court affirmed the verdict in 1984.9Justia. Palmer v. A.H. Robins Co., Inc.
In Minnesota, plaintiff attorney Michael Ciresi won two bellwether verdicts in 1983 totaling $2.5 million with punitive damages, then secured a $38 million settlement in 1984 for his remaining 198 clients after the cases were consolidated before Chief U.S. District Judge Miles Lord.10Ciresi Conlin. Dalkon Shield Litigation It was in a July 1984 deposition taken by Ciresi that Roger Tuttle revealed the 1975 burning of records and produced 13 sensitive documents he had preserved. Court-appointed special masters later concluded there was a “strong prima facie case” that A.H. Robins had engaged in an “ongoing fraud.”11Los Angeles Times. Dalkon Shield Litigation
Bankruptcy and the Claimants Trust
By mid-1985, Robins and its insurers had paid $378.3 million to settle 9,230 cases, with another $107.3 million spent on legal fees. A $615 million reserve set aside in April 1985 was quickly deemed insufficient. On August 21, 1985, A.H. Robins filed for Chapter 11 bankruptcy protection in federal court in Richmond, Virginia.12New York Times. Robins in Bankruptcy Filing Cites Dalkon Shield Claims
U.S. District Judge Robert R. Merhige Jr. oversaw the proceedings. In December 1987 he ordered a trust fund of $2.48 billion to compensate victims. The reorganization plan was confirmed on July 26, 1988. It centered on an acquisition of A.H. Robins by American Home Products Corporation, which exchanged $700 million in stock for Robins shareholders and funded the Dalkon Shield Claimants Trust. Aetna Casualty and Surety Company contributed $425 million in exchange for immunity from future lawsuits. Approximately 95% of claimants voted to approve the plan.13Washington Post. Robins Reorganization Plan Upheld by Appeals Court14EBSCO Research Starters. A.H. Robins Must Compensate Women Injured by Dalkon Shield American Home Products completed the acquisition on December 16, 1989, ending the Robins family’s control of the company.15Los Angeles Times. American Home Products Completes Robins Acquisition
What Claimants Actually Received
The trust processed more than 300,000 personal injury claims from 103 countries. It offered three tracks: a minor-claim payment of $725, predetermined settlement amounts scaled to injury severity, or individual case-by-case negotiation. Of roughly 195,000 women who met the trust’s eligibility criteria, 150,000 settled without counsel, and 99,400 of those accepted the $725 quick-payoff option.16SCIRP. The Dalkon Shield
The trust outperformed expectations. Strong investment returns and low administrative costs allowed supplemental distributions. In 1995, trustees announced $800 million in additional payments to 49,000 women, estimating that claimants would ultimately receive about 75% of their original award amounts. Some received more than twice what they had initially expected.17New York Times. Dalkon Shield Trust to Pay $800 Million18Virginia Lawyers Weekly. Dalkon Shield Trust Shutting Down, Nearly $3B Distributed The trust closed on April 30, 2000, nearly a decade ahead of schedule, having distributed almost $3 billion.1Harvard Law School. Dalkon Shield Litigation Papers Donated to HLS
Claims From Outside the United States
The device was distributed in dozens of countries, in many cases through the U.S. Agency for International Development, which received hundreds of cartons of unsterilized units at a 48 percent discount and shipped them to 42 countries including Paraguay, Thailand, Tunisia, Israel, and Chile.19Mother Jones. A Charge of Gynocide In Australia, more than 100,000 women were fitted with the Shield, and about 6,000 eventually filed claims — the largest cohort from any country outside the United States. Advocates successfully lobbied the U.S. bankruptcy court to appoint a dedicated lawyer to oversee overseas claims, and international claimants were paid through the same trust that handled American cases.20Justice and Equity Centre. Justice for Australian Women Harmed by the Dalkon Shield
What the Litigation Changed
Before the Dalkon Shield, the FDA had no authority to require safety or efficacy testing for medical devices. Only drugs faced federal premarket review. Reports of septic abortions and deaths linked to the Shield helped push Congress to act. On May 28, 1976, President Gerald Ford signed the Medical Device Amendments into law, creating a risk-based classification system, mandating the 510(k) premarket notification process for new devices, and giving the FDA authority to require manufacturer registration, inspect factories and records, ban hazardous devices, and order recalls. Amendments in 1990 and 1992 tightened post-market surveillance requirements for manufacturers, hospitals, and healthcare providers.21National Academies. Medical Device Regulation22FDA. Regulating Devices After 193816SCIRP. The Dalkon Shield
The lawsuits also reshaped the American contraceptive market. Before the Dalkon Shield, more than 10% of American women using contraception relied on IUDs. By the mid-1990s, that figure had fallen below 1%. Manufacturers of other IUDs, including the Lippes Loop, Copper-7, and Copper-T, pulled their products from the U.S. market during the 1980s because the liability exposure had become untenable, not because of safety problems with their own devices. By 1986, only one IUD (Progestasert) remained available in the United States.23Jacobs Institute of Women’s Health, GWU. History of LARC in the United States Physicians grew wary as well. A late-1980s survey of San Diego County doctors found that 40% would not recommend copper IUDs because of liability concerns.24Guttmacher Institute. Checkered History and Bright Future of Intrauterine Contraception
Later IUDs like ParaGard (approved 1984, introduced 1988) and Mirena (approved 2000) were built with monofilament strings that do not wick bacteria, addressing the specific defect that made the Dalkon Shield so dangerous. The stigma outlasted the design flaw. FDA-approved labeling for ParaGard initially recommended that users be in a mutually monogamous relationship and have had at least one child, a restriction that was not removed until 2005.23Jacobs Institute of Women’s Health, GWU. History of LARC in the United States